2.48% -0.59

Rigel Pharmaceuticals (RIGL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.49% 69.80	69.46	101.69	53.33	57.60
Cost Of Revenue	25.29% 5.955	4.753	4.504	4.409	5.789
Gross Profit	1.33% 63.85	64.71	97.18	48.92	51.81
Operating Expenses	12.09% 40.68	36.29	36.08	36.15	35.15
Benefits Costs and Expenses	12.54% 47.09	41.84	41.70	41.82	42.37
Costs And Expenses	13.62% 46.63	41.04	40.58	40.56	40.94
Operating Income/Loss	18.47% 23.17	28.42	61.10	12.77	16.66
Income/Loss From Continuing Operations Before Tax	17.76% 22.71	27.62	59.98	11.51	15.22
Income Tax Expense/Benefit	87,525% -245.35	-0.28	0.369	0.065	-
Income/Loss From Continuing Operations After Tax	860.81% 268.06	27.90	59.61	11.45	14.34
Net Income/Loss	860.81% 268.06	27.90	59.61	11.45	14.34
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.58% 0.075	18.04	17.89	17.81	0.023
Diluted Average Shares	97.59% 0.461	19.16	18.16	18.17	0.088
Basic Earnings Per Share	860.00% 14.88	1.55	3.33	0.64	0.81
Diluted Earnings Per Share	865.75% 14.10	1.46	3.28	0.63	0.81
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%